CPS Technologies Corp. (CPSH) - 10-K Summary
Business Context and Reporting Period
Company: CPS Technologies Corp.
Reporting Period: Fiscal year ended December 27, 2025 (52 weeks).
Business Overview: CPS is a Massachusetts-based advanced materials company specializing in Metal Matrix Composites (MMCs), hermetic packaging, and HybridTech Armor. The company serves high-reliability markets including aerospace, defense, energy, transportation, and electronics. Products are custom-engineered for applications such as NASA Mars rovers, U.S. Navy aircraft carriers, and high-speed electric trains.
Key Financial Metrics (Fiscal Year 2025)
| Metric | 2025 | 2024 |
|---|---|---|
| Total Revenue | $32.6 million | $21.1 million |
| Gross Profit | $5.3 million (16% margin) | $(0.1) million (-1% margin) |
| Operating Income | $0.4 million | $(4.4) million |
| Net Income | $0.4 million | $(3.1) million |
| Cash & Cash Equivalents | $4.5 million | $3.3 million |
| Marketable Securities | $8.8 million | $1.0 million |
| Total Liquidity | $13.3 million | $4.3 million |
| Debt | $0 (No borrowings on $3M LOC) | $0 (No borrowings on $3M LOC) |
| Order Backlog | $26 million | Not disclosed |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 54% year-over-year, driven by core business growth, the addition of a third production shift in late 2024, and the resolution of a major customer quality issue that had previously constrained capacity.
- Profitability Turnaround: The company returned to profitability, moving from a net loss of $3.1 million in 2024 to net income of $0.4 million in 2025. Gross margin improved from -1% to 16% due to operating leverage on fixed costs.
- Gold Price Impact: Rising gold prices increased revenue by $1.4 million (pass-through costs) but reduced gross profit margin by approximately 1% as these costs are recovered without profit.
- Customer Concentration: Concentration increased; the top three customers accounted for 64% of revenue in 2025, up from 58% in 2024.
- Capital Structure: In October 2025, the company completed an equity raise, issuing 3.45 million shares at $3.00/share, netting approximately $9.5 million. This significantly bolstered liquidity.
Outlook, Risks, and Management Commentary
- Guidance & Outlook: Management expects to fund 2026 operations from existing cash balances and profits. The company is actively pursuing a move to a larger facility to support anticipated growth, though this poses transition risks.
- Product Pipeline: Active development includes lightweighting solutions for the U.S. Marine Corps Amphibious Combat Vehicle (ACV) and new SBIR-funded projects for radiation shielding and missile thermal management.
- Key Risks:
- Customer Concentration: Heavy reliance on a small number of customers (top 3 = 64% of revenue) creates vulnerability to order cancellations or delays.
- Supply Chain & Vendors: Reliance on sole-sourced vendors for specific manufacturing steps (e.g., plating) creates margin and delivery risks.
- Facility Relocation: Potential disruption to operations and increased costs associated with moving to a larger facility.
- Cybersecurity: As a defense contractor, the company faces risks related to CMMC compliance and potential cyber-attacks on Controlled Unclassified Information (CUI).
- Unusual Items: The filing notes the lessor of the company's Norton, MA facility was placed in receivership in December 2025; management does not anticipate a significant negative impact.
Investor Verification Checklist
- Customer Dependency: Verify the stability of contracts with the top three customers, which represent nearly two-thirds of revenue.
- Facility Transition: Monitor progress and costs associated with the planned relocation to a larger facility to ensure it does not disrupt the $26 million backlog.
- Gold Cost Pass-Through: Assess the sustainability of gross margins given the volatility of gold prices and the company's ability to pass these costs through without losing market share.
- SBIR Commercialization: Track the transition of government-funded SBIR/STTR projects (e.g., ACV armor, radiation shielding) into commercial Phase III contracts.
- Liquidity Usage: Monitor the deployment of the $9.5 million equity raise proceeds to ensure they are utilized for growth initiatives rather than covering operational inefficiencies.